0001731122-20-000243.txt : 20200311 0001731122-20-000243.hdr.sgml : 20200311 20200311132732 ACCESSION NUMBER: 0001731122-20-000243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190827 FILED AS OF DATE: 20200311 DATE AS OF CHANGE: 20200311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yeap Arthur CENTRAL INDEX KEY: 0001421562 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09927 FILM NUMBER: 20704783 MAIL ADDRESS: STREET 1: 1211 N. WESTSHORE BLVD. STREET 2: SUITE 512 CITY: TAMPA STATE: FL ZIP: 33607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Advanzeon Solutions, Inc. CENTRAL INDEX KEY: 0000022872 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 952594724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 BUSINESS PHONE: 813-288-4808 MAIL ADDRESS: STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD. STREET 2: SUITE 101 CITY: TAMPA STATE: FL ZIP: 33607 FORMER COMPANY: FORMER CONFORMED NAME: COMPREHENSIVE CARE CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES DATE OF NAME CHANGE: 19730501 FORMER COMPANY: FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC DATE OF NAME CHANGE: 19700402 4 1 ownership.xml X0306 4 2019-08-27 0 0000022872 Advanzeon Solutions, Inc. CHCR 0001421562 Yeap Arthur C/O 2901 W. BUSCH BLVD., SUITE 701 TAMPA FL 33618 1 0 0 0 Common Stock 2019-08-27 4 J 0 2500000 .00 A 3675000 D The Board of Directors on August 26, 2019, changed the vesting date of the Issuer's Series D Preferred Stock from January 4, 2022 to August 27, 2019. Each share of the Series D Preferred Stock converts into 100,000 shares of the Issuers Common Stock. The Reporting Person owns 25 shares of the Series D Preferred Stock which are convertible into 2, 500,000 shares of the Issuers' Common Stock at any time. This amount includes 322,829 shares of common stock, options to purchase 775,000 shares of common stock, 77,171 shares obtainable from the conversion of 244 shares of the Series C Preferred Stock and 2,500,000 shares obtainable from the conversion of 25 shares of Series D Preferred Stock. /s/Arthur K. Yeap 2020-03-11